| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Dermatology and University of California San Francisco Cancer Center, University of California, San Francisco, California 94143-0808
The lesion-specific DNA polymerase POLH gene is mutated in xeroderma pigmentosum variant (XP-V) patients who exhibit an increased skin cancer incidence from UV exposure. Normal cells in which POLH expression was reduced using short interfering RNAs (siRNAs) were compared with the XP-V cellular phenotype that results from naturally occurring inactivating mutations. Stable clones expressing siRNA had partially reduced POLH protein levels, and intermediate levels of UV sensitivity and S phase checkpoint activation, but similar levels of Mre11 foci as in XP-V cells. Therefore, suppression of POLH expression levels by siRNA recapitulates most of the phenotypes seen in cells from XP-V patients with inactivating mutations in POLH.
This article has been cited by other articles:
![]() |
Y.-w. Chen, J. E. Cleaver, Z. Hatahet, R. E. Honkanen, J.-Y. Chang, Y. Yen, and K.-m. Chou Human DNA polymerase {eta} activity and translocation is regulated by phosphorylation PNAS, October 28, 2008; 105(43): 16578 - 16583. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-w. Chen, J. E. Cleaver, F. Hanaoka, C.-f. Chang, and K.-m. Chou A Novel Role of DNA Polymerase {eta} in Modulating Cellular Sensitivity to Chemotherapeutic Agents Mol. Cancer Res., April 1, 2006; 4(4): 257 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu and X. Chen DNA Polymerase {eta}, the Product of the Xeroderma Pigmentosum Variant Gene and a Target of p53, Modulates the DNA Damage Checkpoint and p53 Activation Mol. Cell. Biol., February 15, 2006; 26(4): 1398 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S.F. Biard, E. Despras, A. Sarasin, and J. F. Angulo Development of New EBV-Based Vectors for Stable Expression of Small Interfering RNA to Mimick Human Syndromes: Application to NER Gene Silencing Mol. Cancer Res., September 1, 2005; 3(9): 519 - 529. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |